What should I pay attention to while taking dasatinib?

Dasatinib (Dasatinib) is an effective anti-tumor drug, specifically targeted for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) that is resistant or intolerant to imatinib mesylate. Dasatinib is mainly used to treat the chronic phase, accelerated phase and blast phase of chronic myeloid leukemia (CML), especially for patients who are resistant or intolerant to imatinib mesylate.

Dasatinib inhibits specific protein kinases and blocks the proliferation of abnormal white blood cells, thereby controlling the disease. The dosage is adjusted according to different stages of the disease. Generally, the recommended starting dose for CML in the chronic phase is 100 mg per day, while for patients in the accelerated or blast phase, the starting dose may be 70 mg per day, and the dose may need to be adjusted based on the efficacy.

You should pay attention to the following points while taking dasatinib:

Communication with your doctor: Before starting treatment and during treatment, you should communicate with your doctor regularly to report any discomfort or abnormal reactions.

Regular monitoring: Routine blood tests, liver function and other tests need to be carried out regularly to detect possible side effects of the drug in a timely manner, such as bone marrow suppression or liver function damage.

Medication Instructions: Dasatinib should be taken with or after food to reduce stomach upset. Tablets should be swallowed whole and not broken, crushed, or chewed.

Observation of side effects: Pay attention to the occurrence of common side effects such as pleural effusion, rash, nausea, vomiting, diarrhea, etc. If any occur, seek medical attention in time.

Pregnancy and Contraception: Pregnancy should be avoided while taking this drug, and both male and female patients should take contraceptive measures during treatment and for a period of time after stopping the drug.

Avoid certain drugs and foods: For example, antacids, grapefruit or grapefruit juice should be avoided while taking dasatinib to avoid affecting the effectiveness of the drug.

In general, dasatinib is an effective anti-tumor drug, but patients need to carefully observe their physical condition and maintain close communication with their doctors during taking it to ensure the safety and effectiveness of the treatment.